Infectious Disease Doctors in Amarillo, TX Accepting Medicare

6 Infectious Disease doctors found. Showing 1 - 6

John Scott Milton, MD Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 1400 S Coulter St, Amarillo, TX 79106 Phone: 806-354-5480    Fax: 806-354-5764

Tarek H Naguib, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1215 S Coulter St, Suite 404, Amarillo, TX 79106 Phone: 806-358-8477    Fax: 806-677-7639

Dr. Pablo S Rodriguez, MD Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 1215 S Coulter St, Suite 401, Amarillo, TX 79106 Phone: 806-356-2280    Fax: 806-677-2029

Joseph Taylor Carlisle, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6700 W 9th Ave, Amarillo, TX 79106 Phone: 806-358-0200    Fax: 806-356-5590

Abhijit Gajendra Gutal, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 1400 S Coulter St, Suite 2500, Amarillo, TX 79106 Phone: 806-414-9100

Deepak Garg, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6700 W 9th Ave, Amarillo, TX 79106 Phone: 806-358-0200    Fax: 806-356-5590

News Archive

Research to help people born with 'face blindness'

A specific area in our brains is responsible for processing information about human and animal faces, both how we recognize them and how we interpret facial expressions. Now, Tel Aviv University research is exploring what makes this highly specialized part of the brain unique, a first step to finding practical applications for that information.

Allergan's investigational medication rapastinel granted FDA Breakthrough Therapy designation

Allergan plc., a leading global pharmaceutical company today announced that its Phase III ready investigational medication rapastinel (GLYX-13) received Breakthrough Therapy designation from the U.S. Food and Drug Administration for adjunctive treatment of Major Depressive Disorder (MDD).

Researchers reveal new mechanism of pain control

Researchers in Japan have revealed a previously unknown mechanism for pain control involving a newly identified group of cells in the spinal cord, offering a potential target for enhancing the therapeutic effect of drugs for chronic pain.

California teens do not get regular physical activity

Teenage girls, teens from low-income families, teens with no access to safe parks or open spaces, teens whose schools do not require physical education, and Latino, Asian, and African American teens are particularly at risk according to researchers at the UCLA Center for Health Policy Research.

Study: Youth with type1 diabetes who use insulin pumps less likely to develop diabetic retinopathy

In one of the largest and most racially diverse studies to date of American children and adolescents with type 1 and type 2 diabetes, researchers at Johns Hopkins Medicine, Baylor College of Medicine and the University of Wisconsin have identified the clinical and demographic factors associated with pediatric diabetic retinopathy.

Read more Medical News

› Verified 8 days ago